Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001904.4(CTNNB1):c.337C>T(p.Gln113*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
CTNNB1 (HGNC:2514): (catenin beta 1) The protein encoded by this gene is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. Finally, this protein binds to the product of the APC gene, which is mutated in adenomatous polyposis of the colon. Mutations in this gene are a cause of colorectal cancer (CRC), pilomatrixoma (PTR), medulloblastoma (MDB), and ovarian cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]
CTNNB1 Gene-Disease associations (from GenCC):
exudative vitreoretinopathy
Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
severe intellectual disability-progressive spastic diplegia syndrome
Our verdict: Pathogenic. The variant received 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 3-41225049-C-T is Pathogenic according to our data. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-41225049-C-T is described in CliVar as Pathogenic. Clinvar id is 451713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 27915094, 24668549, 33057194, 35982159) -
Severe intellectual disability-progressive spastic diplegia syndromePathogenic:1
Oct 05, 2017
Geisinger Autism and Developmental Medicine Institute, Geisinger Health System
This variant was identified in a 15 year old female with severe intellectual disability, cerebral palsy and dysarthria that are all consistent with CTNNB1-related disorder. Specifically, her cerebral palsy is characterized by significant bilateral lower extremity hypertonus, primarily spastic but mixed quality that is consistent with this disorder. The c.337C>T variant was found to be de novo (PS2); maternity and paternity were confirmed.. The variant is absent from the ExAC and gnomAD databases (PM2). The variant is also an expected null variant in a gene where loss of function is a known mechanism of disease (PVS1). This variant was identified in a similary affected sibling suggesting potential germline mosaicism in a parent. -